Kronos raises seed round, names Bischofberger CEO

Cancer company Kronos Bio Inc. (Cambridge, Mass.) raised $18 million in seed financing Wednesday and hired Norbert Bischofberger as president and CEO. Bischofberger was EVP of R&D

Read the full 272 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE